Samsung Biologics Co Data, Technology Stack, and Enterprise Applications
Analytics and BI
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Microsoft Legacy Microsoft Power BI Analytics and BI Analytics and BI n/a 2021 2021
Process Mining Analytics and BI 2021 2021
IaaS
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Microsoft Legacy Microsoft Azure Cloud Services Application Hosting and Computing Services IaaS n/a 2021 2021
Application Hosting and Computing Services IaaS 2021 2021
PaaS
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Red Hat Legacy Red Hat Enterprise Linux Apps Development PaaS n/a 2021 2021
Collaboration
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Collaboration Collaboration 2021 2021
Content Management
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Document Management Content Management 2020 2020
ERP Financial Management
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
ERP Financial ERP Financial Management 2021 2022
CyberSecurity
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Identity and Access Management (IAM) CyberSecurity 2022 2022
Identity and Access Management (IAM) CyberSecurity 2022 2022
Secure Sockets Layer (SSL) CyberSecurity 2022 2022
Web Application Firewalls (WAF) CyberSecurity 2021 2021
PLM and Engineering
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Quality Management PLM and Engineering 2020 2020
IT Decision Makers and Key Stakeholders at Samsung Biologics Co
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Samsung Biologics Co Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Samsung Biologics Co Technographics

Samsung Biologics Co is a Life Sciences organization based in South Korea, with around 4400 employees and annual revenues of $1.20 billion.

Samsung Biologics Co operates a diverse technology stack with applications such as Microsoft Power BI, Microsoft Azure Cloud Services and Red Hat Enterprise Linux, covering areas like Analytics and BI, Application Hosting and Computing Services and Apps Development.

Samsung Biologics Co has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Microsoft and Red Hat.

Samsung Biologics Co recently adopted applications including Google Identity Platform in 2022, SailPoint Identity Platform in 2022 and Sectigo SSL in 2022, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Samsung Biologics Co’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Samsung Biologics Co’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Samsung Biologics Co technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.